• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌细胞

Ovarian cancer stem cells.

机构信息

Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Neoplasma. 2012;59(6):747-55. doi: 10.4149/neo_2012_094.

DOI:10.4149/neo_2012_094
PMID:22862176
Abstract

Because of its semi-solid character in dissemination and growth, advanced ovarian cancer with its hundreds of peritoneal tumor nodules and plaques appears to be an excellent in vivo model for studying the cancer stem cell hypothesis. The most important obstacle, however, is to adequately define and isolate these tumor-initiating cells endowed with the properties of anoikis-resistance and unlimited self-renewal. Until now, no universal single marker or marker constellation has been found to faithfully isolate (ovarian) cancer stem cells. As these multipotent cells are known to possess highly elaborated efflux systems for cytotoxic agents, these pump systems have been exploited to outline putative stem cells as a side-population (SP) via dye exclusion analysis. Furthermore, the cells in question have been isolated via flow cytometry on the basis of cell surface markers thought to be characteristic for stem cells.In the Vienna variant of the ovarian cancer cell line A2780 a proof-of-principle model with both a stable SP and a stable ALDH1A1+ cell population was established. Double staining clearly revealed that both cell fractions were not identical. Of note, A2780V cells were negative for expression of surface markers CD44 and CD117 (c-kit). When cultured on monolayers of healthy human mesothelial cells, green-fluorescence-protein (GFP)-transfected SP of A2780V exhibited spheroid-formation, whereas non-side-population (NSP) developed a spare monolayer growing over the healthy mesothelium. Furthermore, A2780V SP was found to be partially resistant to platinum. However, this resistance could not be explained by over-expression of the "excision repair cross-complementation group 1" (ERCC1) gene, which is essentially involved in the repair of platinated DNA damage. ERCC1 was, nonetheless, over-expressed in A2780V cells grown as spheres under stem cell-selective conditions as compared to adherent monolayers cultured under differentiating conditions. The same was true for the primary ovarian cancer cells B-57.In summary our investigations indicate that even in multi-passaged cancer cell lines hierarchic government of growth and differentiation is conserved and that the key cancer stem cell population may be composed of small overlapping cell fractions defined by various arbitrary markers.

摘要

由于其在传播和生长过程中的半固态特性,具有数百个腹膜肿瘤结节和斑块的晚期卵巢癌似乎是研究癌症干细胞假说的极佳体内模型。然而,最重要的障碍是充分定义和分离这些具有抗失巢凋亡和无限自我更新能力的肿瘤起始细胞。到目前为止,尚未发现通用的单一标志物或标志物组合能够忠实地分离(卵巢)癌症干细胞。由于这些多能细胞已知具有高度精细的细胞毒性药物外排系统,因此这些泵系统已被用于通过染料排除分析来描绘假定的干细胞作为侧群(SP)。此外,这些有问题的细胞已通过基于被认为是干细胞特征的细胞表面标志物的流式细胞术进行分离。在卵巢癌细胞系 A2780 的维也纳变体中,建立了一个具有稳定 SP 和稳定 ALDH1A1+细胞群体的原理验证模型。双重染色清楚地表明,这两个细胞群并不完全相同。值得注意的是,A2780V 细胞对表面标志物 CD44 和 CD117(c-kit)的表达呈阴性。当在健康人间皮细胞单层上培养时,GFP 转染的 A2780V SP 表现出球体形成,而非侧群(NSP)在健康间皮上形成单层生长。此外,发现 A2780V SP 对铂具有部分抗性。然而,这种抗性不能用“切除修复交叉互补组 1”(ERCC1)基因的过度表达来解释,该基因主要参与铂化 DNA 损伤的修复。然而,与在分化条件下培养的贴壁单层相比,在干细胞选择性条件下生长的 A2780V 细胞球体中 ERCC1 过度表达。原发性卵巢癌细胞 B-57 也是如此。总之,我们的研究表明,即使在多代传代的癌细胞系中,生长和分化的层次结构也得以保留,并且关键的癌症干细胞群体可能由通过各种任意标志物定义的小重叠细胞群组成。

相似文献

1
Ovarian cancer stem cells.卵巢癌细胞
Neoplasma. 2012;59(6):747-55. doi: 10.4149/neo_2012_094.
2
The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells.ERCC1基因第八外显子可变剪接对卵巢癌细胞顺铂耐药性的影响。
Cancer Invest. 2009 Nov;27(9):891-7. doi: 10.3109/07357900902744536.
3
Human ovarian cancer stem cells.人卵巢癌细胞。
Reproduction. 2010 Jul;140(1):33-41. doi: 10.1530/REP-09-0389. Epub 2010 Mar 16.
4
Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.从人胶质母细胞瘤细胞系 SK-MG-1 的侧群中分离出癌症干细胞样细胞。
Cancer Lett. 2010 May 28;291(2):150-7. doi: 10.1016/j.canlet.2009.10.010. Epub 2009 Nov 13.
5
Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.丹参酮 IIA 通过 p38 MAPK 诱导凋亡及下调顺铂耐药卵巢癌细胞中的 ERCC1 和肺耐药蛋白。
Oncol Rep. 2011 Mar;25(3):781-8. doi: 10.3892/or.2010.1107. Epub 2010 Dec 13.
6
Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.通过干扰卵巢癌细胞系中的核苷酸切除修复途径增强顺铂细胞毒性。
Cancer Res. 2003 Mar 15;63(6):1311-6.
7
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome.具有 CD117 表型的卵巢癌细胞具有高度致瘤性,并与化疗结果相关。
Exp Mol Pathol. 2011 Oct;91(2):596-602. doi: 10.1016/j.yexmp.2011.06.005. Epub 2011 Jul 20.
8
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.在用蛋白酶体抑制剂PS - 341治疗的人类卵巢癌和前列腺癌中未观察到多细胞耐药性。
Clin Cancer Res. 2000 Sep;6(9):3719-28.
9
Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.RhoC下调对抑制卵巢癌干细胞增殖、耐药性、侵袭和转移的作用及机制
Oncol Rep. 2016 Dec;36(6):3267-3274. doi: 10.3892/or.2016.5164. Epub 2016 Oct 11.
10
[Relationship between nucleotide excision repair gene ERCC1 and resistance to cisplatin in ovarian cancer].[核苷酸切除修复基因ERCC1与卵巢癌顺铂耐药性的关系]
Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):184-7.

引用本文的文献

1
Endothelial OX40 activation facilitates tumor cell escape from T cell surveillance through S1P/YAP-mediated angiogenesis.内皮细胞OX40激活通过S1P/YAP介导的血管生成促进肿瘤细胞逃避T细胞监视。
J Clin Invest. 2025 Mar 3;135(5):e186291. doi: 10.1172/JCI186291.
2
Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.足细胞蛋白促进高级别浆液性卵巢癌中紧密且耐药的肿瘤球的形成。
Sci Rep. 2024 Mar 30;14(1):7539. doi: 10.1038/s41598-024-57053-7.
3
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
宿主微生物组的区室化:肿瘤微生物组如何塑造检查点免疫治疗的结果并提供治疗前景。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-005401.
4
Extracts of the Medicinal Plants and Inhibit Ovarian Cancer Stem Cells .药用植物提取物抑制卵巢癌干细胞。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221123019. doi: 10.1177/15347354221123019.
5
Metabolic Reprogramming and Lipophagy Mediates Survival of Ascites Derived Metastatic Ovarian Cancer Cells.代谢重编程和脂噬介导腹水来源转移性卵巢癌细胞的存活。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1699-1709. doi: 10.31557/APJCP.2022.23.5.1699.
6
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.利用G蛋白偶联受体作为分子信标,用纳米药物靶向卵巢癌。
Cancers (Basel). 2022 May 10;14(10):2362. doi: 10.3390/cancers14102362.
7
Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.腹水助力卵巢癌细胞的转移之旅:各种细胞成分的协同作用。
Int J Mol Sci. 2022 Apr 15;23(8):4383. doi: 10.3390/ijms23084383.
8
Ovarian Cancer and Cancer Stem Cells-Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology.卵巢癌与癌症干细胞——细胞和分子特征、信号通路以及在医学和肿瘤学中作为诊断工具的用途
Cancers (Basel). 2021 Aug 19;13(16):4178. doi: 10.3390/cancers13164178.
9
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.卵巢癌中高 RIG-I 表达与免疫逃避特征和不良临床结局相关。
Int J Cancer. 2020 Apr 1;146(7):2007-2018. doi: 10.1002/ijc.32818. Epub 2019 Dec 19.
10
CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1.CD44表达通过调控Snail、ZEB1和小窝蛋白-1促进上皮-间质转化(EMT)来预测卵巢癌患者的预后。
Front Oncol. 2019 Aug 21;9:802. doi: 10.3389/fonc.2019.00802. eCollection 2019.